Clinical course of patients with nonclassical 21-hydroxylase deficiency (21-OHD) diagnosed in infancy and childhood

Endocrine Journal

Volumn 55, Issue 2, 2008, Pages 397-404

  Kashimada, Ken Ichi ^a   Ono, Makoto ^a   Onishi, Toshikazu ^a   Koyama, Satimi ^a   Toyoura, Takio ^a   Imai, Kazuhide ^b   Saisho, Sumitaka ^a   Mizutani, Shuki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

Author keywords

17 hydroxyprogesterone (17 OHP); 21 hydoxylase deficiency (21 OHD) nonclassical type; Congenital adrenal hyperplasia (CAH); Neonatal mass screening

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; HYDROCORTISONE; TETRACOSACTIDE;

ADRENAL INSUFFICIENCY; ARTICLE; BIRTH; BODY GROWTH; BODY HEIGHT; BONE MATURATION; CASE REPORT; CHILD; CHILDHOOD DISEASE; DISEASE COURSE; FEMALE; GENE MUTATION; HORMONAL THERAPY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INFANT; LOADING TEST; MALE; NEWBORN PERIOD; SIBLING; STEROID 21 MONOOXYGENASE DEFICIENCY; VIRILIZATION; VIRUS INFECTION;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH AND DEVELOPMENT; HUMANS; HYDROCORTISONE; MALE; PEDIGREE; PROGNOSIS; STEROID 21-HYDROXYLASE;

EID: 43449120436     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-057     Document Type: Article

References (20)

1. New MI (2006) Extensive clinical experience: nonclassical (2006) 21-hydroxylase deficiency. J Clin Endocrinol Metab 11: 4205-4214.
2. Newfield RS, New MI (1997) 21-hydroxylase deficiency. Ann N Y Acad Sci 17: 219-229.
3. Perrin C. White, Phyllis W. Speiser (2000) Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Endocrine Reviews 21: 245-291.
4. White PC, New MI, Dupont B (1987) Congenital Adrenal Hyperplasia. N Engl J Med 316: 1519-1524.
5. Speiser PW, White PC (2003) Congenital adrenal hyperplasia. N Engl J Med 349: 776-788.
6. Merke DP, Bornstein SR (2005) Congenital adrenal hyperplasia. Lancet 365: 2125-2136.
7. Azziz R, Dewailly D, Owerbach D (1994) Nonclassic adrenal hyperplasia: current concepts. J Clin Endocrinol Metab 78: 810-815.
8. Kohn B, Levine LS, Pollack MS, Pang S, Lorenzen F, Levy D, Lerner AJ, Rondanini GF, Dupont B, New MI (1982) Late-onset steroid 21-hydroxylase deficiency: a variant of classical congenital adrenal hyperplasia. J Clin Endocrinol Metab 55: 817-827.
9. Panista-Faflia CH, Batrinos ML Late-onset (1997) Congenital Adrenal Hyperplasia. Ann N Y Acad Sci 816: 230-234.
10. Speiser PW, New MI (1987) Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 64: 86-91.
11. Tajima T, Fujieda K, Nakae J, Toyoura T, Shimozawa K, Kusuda S, Goji K, Nagashima T, Cutler GB Jr. (1997) Molecular basis of nonclassical steroid 21-hydroxylase deficiency detected by neonatal mass screening in Japan. J Clin Endocrinol Metab 82: 2350-2356.
12. Tajima T, Fujieda K, Nakae J, Mikami A, Cutler GB Jr. (1998) Mutations of the CYP21 gene in nonclassical steroid 21-hydroxylase deficiency in Japan. Endocr J 45: 493-497.
13. Saisho S, Shimozawa K, Yata J (1990) Changes of several adrenal delta 4-steroids measured by HPLC-UV spectrometry in neonatal patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm Res 33: 27-34.
14. Koyama S, Toyoura T, Saisho S, Shimozawa K, Yata J (2002) Genetic analysis of Japanese patients with 21-hydroxylase deficiency: identification of a patient with a new mutation of a homozygous deletion of adenine at codon 246 and patients without demonstrable mutations within the structural gene for CYP21. J Clin Endocrinol Metab 87: 2668-2673.
15. New MI, Gertner JM, Speiser PW, del Balzo P (1998) Growth and final height in classical and nonclassical 21-hydroxylase deficiency. Acta Paediatr Jpn 30: 79-88.
16. Bachega TA, Billerbeck AE, Marcondes JA, Madureira G, Arnhold IJ, Mendonca BB (2000) Influence of different genotypes on 17-hydroxyprogesterone levels in patients with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 52: 601-607.
17. Weintrob N, Dickerman Z, Sprecher E, Galatzer A, Pertzelan A (1997) Nonclassical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height. Eur J Endocrinol 136: 188-195.
18. Wilson RC, Mercado AB, Cheng KC, New MI (1995) Steroid 21-hydroxylase deficiency: genotype may not predict phenotype. J Clin Endocrinol Metab 80: 2322-2329.
19. Levine LS, Dupont B, Lorenzen F, Pang S, Pollack M, Oberfield SE, Kohn B, Lerner A, Cacciari E, Mantero F, Cassio A, Scaroni C, Chiumello G, Rondanini GF, Gargantini L, Giovannelli G, Virdis R, Bartolotta E, Migliori C, Pintor C, Tato L, Barboni F, New MI (1981) Genetic and hormonal characterization of cryptic 21-hydroxylase deficiency. J Clin Endocrinol Metab 53: 1193-1198.
20. Weintrob N, Brautbar C, Pertzelan A, Josefsberg Z, Dickerman Z, Kauschansky A, Lilos P, Peled D, Phillip M, Israel S (2000) Genotype-phenotype associations in nonclassical steroid 21-hydroxylase deficiency. Eur J Endocrinol 143: 397-403.